Real-world utilization of multiple myeloma treatments in the era of novel therapies: What is the current standard of care?

e20019Background: Historically, few FDA approved treatments for multiple myeloma (MM) were available, with bortezomib and lenalidomide considered the standard of care. Recently, several new treatme...